• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.

作者信息

Langreth S G, Berman J D, Riordan G P, Lee L S

出版信息

J Protozool. 1983 Aug;30(3):555-61. doi: 10.1111/j.1550-7408.1983.tb01421.x.

DOI:10.1111/j.1550-7408.1983.tb01421.x
PMID:6315928
Abstract

The mechanism of action of antileishmanial compounds is poorly understood. Ultrastructural changes in Leishmania tropica within human macrophages exposed in vitro to Pentostam, pentamidine, amphotericin B, WR 6026, ketoconazole, and Formycin B were examined in these experiments. In Pentostam-treated cultures, some organisms exhibited diminished definition of mitochondrial and other membranes, while other organisms had completely disintegrated. Pentostam-exposed macrophages demonstrated loss of membrane definition in the absence of further alterations; it is therefore hypothesized that impaired macrophage membrane function may contribute towards the effect of this drug against macrophage-contained organisms. Leishmania parasites in pentamidine-treated cultures initially demonstrated swollen kinetoplasts and fragmentation of the kinetoplast DNA core. The initial observed effect of the other four drugs on the parasites was cytoplasmic condensation. These ultrastructural studies suggest that all five non-antimonial drugs may have different mechanisms of action than antimony (Pentostam) against Leishmania.

摘要

相似文献

1
Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.
J Protozool. 1983 Aug;30(3):555-61. doi: 10.1111/j.1550-7408.1983.tb01421.x.
2
Semiautomated assessment of in vitro activity of potential antileishmanial drugs.潜在抗利什曼原虫药物体外活性的半自动评估
Antimicrob Agents Chemother. 1985 Dec;28(6):723-6. doi: 10.1128/AAC.28.6.723.
3
Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.抗利什曼原虫药物对人单核细胞衍生巨噬细胞和小鼠腹腔巨噬细胞中无鞭毛体的活性。
J Parasitol. 1984 Apr;70(2):220-5.
4
Activity of purine analogs against Leishmania tropica within human macrophages in vitro.嘌呤类似物在体外对人巨噬细胞内热带利什曼原虫的活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):233-6. doi: 10.1128/AAC.24.2.233.
5
Activity of oral drugs against Leishmania tropica in human macrophages in vitro.口服药物对体外培养的人巨噬细胞中热带利什曼原虫的活性。
Am J Trop Med Hyg. 1983 Sep;32(5):947-51. doi: 10.4269/ajtmh.1983.32.947.
6
The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.吡唑并嘧啶与五价锑对杜氏利什曼原虫和巴西利什曼原虫的协同作用。
Am J Trop Med Hyg. 1988 Sep;39(3):250-5. doi: 10.4269/ajtmh.1988.39.250.
7
Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.杜氏利什曼原虫:锑耐药两性霉素B敏感分离株的体外研究
Exp Parasitol. 2006 Dec;114(4):247-52. doi: 10.1016/j.exppara.2006.03.016. Epub 2006 May 23.
8
An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.一种用于测定化合物对杜氏利什曼原虫细胞内无鞭毛体形式活性的体外系统。
J Antimicrob Chemother. 1984 Nov;14(5):463-75. doi: 10.1093/jac/14.5.463.
9
Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.甘草酸与抗利什曼原虫药物葡萄糖酸锑钠(SAG)联合用药可治愈 SAG 耐药性内脏利什曼病。
Int J Antimicrob Agents. 2015 Mar;45(3):268-77. doi: 10.1016/j.ijantimicag.2014.10.023. Epub 2014 Dec 8.
10
Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.葡萄糖酸锑钠和喷他脒对来自感染及药物处理的BALB/c小鼠腹腔巨噬细胞内杜氏利什曼原虫体外增殖的影响。
Immunol Cell Biol. 1992 Feb;70 ( Pt 1):25-31. doi: 10.1038/icb.1992.4.

引用本文的文献

1
A comprehensive revision on the use of quinoline antimalarial drugs as leishmanicidal agents.关于将喹啉抗疟药物用作杀利什曼原虫剂的全面修订。
Front Chem. 2025 May 30;13:1608340. doi: 10.3389/fchem.2025.1608340. eCollection 2025.
2
An Overview on the Therapeutics of Neglected Infectious Diseases-Leishmaniasis and Chagas Diseases.被忽视的传染病——利什曼病和恰加斯病的治疗概述
Front Chem. 2021 Mar 12;9:622286. doi: 10.3389/fchem.2021.622286. eCollection 2021.
3
Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.
西他喹啉作为一种潜在的抗利什曼原虫药物候选物:从作用机制到耐药风险。
Parasite. 2011 May;18(2):115-9. doi: 10.1051/parasite/2011182115.
4
Structures, targets and recent approaches in anti-leishmanial drug discovery and development.抗利什曼原虫药物研发中的结构、靶点及近期方法
Open Med Chem J. 2011;5:31-9. doi: 10.2174/1874104501105010031. Epub 2011 Mar 9.
5
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.口服2-取代喹啉对实验性小鼠皮肤利什曼病和内脏利什曼病的疗效。
Antimicrob Agents Chemother. 2005 Dec;49(12):4950-6. doi: 10.1128/AAC.49.12.4950-4956.2005.
6
Antileishmanial activity of an indole alkaloid from Peschiera australis.来自南方佩氏花的一种吲哚生物碱的抗利什曼原虫活性。
Antimicrob Agents Chemother. 2001 May;45(5):1349-54. doi: 10.1128/AAC.45.5.1349-1354.2001.
7
Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.葡萄糖酸锑钠抗利什曼原虫活性的生化机制
Antimicrob Agents Chemother. 1985 Jun;27(6):916-20. doi: 10.1128/AAC.27.6.916.
8
Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.两种麦角固醇生物合成抑制剂酮康唑和特比萘芬对克氏锥虫(裂殖锥虫)前鞭毛体和无鞭毛体诱导的超微结构改变
Antimicrob Agents Chemother. 1990 Nov;34(11):2097-105. doi: 10.1128/AAC.34.11.2097.
9
Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.ICI 195,739(一种对克氏锥虫(分裂锥虫属)具有强大抗增殖作用的双三唑衍生物)诱导的超微结构改变。
Antimicrob Agents Chemother. 1991 Apr;35(4):736-40. doi: 10.1128/AAC.35.4.736.